LSE:IQAI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. More Details


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has IQ-AI's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IQAI is more volatile than 90% of UK stocks over the past 3 months, typically moving +/- 55% a week.

Volatility Over Time: IQAI's weekly volatility has increased from 31% to 55% over the past year.


Market Performance


7 Day Return

40.0%

IQAI

3.4%

GB Healthcare Services

-0.3%

GB Market


1 Year Return

139.3%

IQAI

0.2%

GB Healthcare Services

-11.0%

GB Market

Return vs Industry: IQAI exceeded the UK Healthcare Services industry which returned 8.3% over the past year.

Return vs Market: IQAI exceeded the UK Market which returned -10% over the past year.


Shareholder returns

IQAIIndustryMarket
7 Day40.0%3.4%-0.3%
30 Day194.7%16.8%10.2%
90 Day174.5%16.5%6.4%
1 Year139.3%139.3%2.1%0.2%-7.4%-11.0%
3 Year220.0%220.0%32.1%24.6%0.9%-11.5%
5 Yearn/a31.1%19.2%26.5%-2.5%

Long-Term Price Volatility Vs. Market

How volatile is IQ-AI's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IQ-AI undervalued compared to its fair value and its price relative to the market?

15.08x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate IQAI's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate IQAI's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: IQAI is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.

PE vs Market: IQAI is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IQAI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IQAI is overvalued based on its PB Ratio (15.1x) compared to the GB Healthcare Services industry average (4.7x).


Next Steps

Future Growth

How is IQ-AI forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IQ-AI has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has IQ-AI performed over the past 5 years?

-30.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IQAI is currently unprofitable.

Growing Profit Margin: IQAI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IQAI is unprofitable, and losses have increased over the past 5 years at a rate of 30.3% per year.

Accelerating Growth: Unable to compare IQAI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IQAI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-14.6%).


Return on Equity

High ROE: IQAI has a negative Return on Equity (-62.37%), as it is currently unprofitable.


Next Steps

Financial Health

How is IQ-AI's financial position?


Financial Position Analysis

Short Term Liabilities: IQAI's short term assets (£1.1M) exceed its short term liabilities (£257.6K).

Long Term Liabilities: IQAI has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: IQAI is debt free.

Reducing Debt: IQAI currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IQAI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: IQAI has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 17.5% each year.


Next Steps

Dividend

What is IQ-AI current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IQAI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IQAI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IQAI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IQAI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IQAI's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average board tenure


CEO

Trevor Brown (74 yo)

5.75yrs

Tenure

UK£65,000

Compensation

Mr. Trevor Edward Brown, MBA, has been the Chief Executive Officer at Braveheart Investment Group plc since August 24, 2015 and IQ-AI Limited (formerly known as Flying Brands Limited) since February 13, 20...


CEO Compensation Analysis

Compensation vs Market: Trevor's total compensation ($USD86.66K) is below average for companies of similar size in the UK market ($USD345.93K).

Compensation vs Earnings: Trevor's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Trevor Brown
CEO & Director5.75yrsUK£65.00kno data
Michael Schmainda
Non-Executive Director0.92yrno data5.67%
£ 1.3m
Vinod Kaushal
Non-Executive Director3.83yrsUK£30.00kno data
Qu Li
Non-Executive Chairman5yrsUK£30.00kno data

4.4yrs

Average Tenure

Experienced Board: IQAI's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.5%.


Top Shareholders

Company Information

IQ-AI Limited's company bio, employee growth, exchange listings and data sources


Key Information


Number of Employees


Location

  • IQ-AI Limited
  • Grenville Street
  • Forum 4
  • Saint Helier
  • JE4 8TQ
  • Jersey

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IQAILSE (London Stock Exchange)YesOrdinary SharesGBGBPJun 2017
FLBS.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJun 2017

Biography

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software pl...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/26 19:11
End of Day Share Price2020/11/26 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.